By the first quarter of 2026, tirzepatide had become the most frequently prescribed agent at roughly 4,700 prescriptions per 100,000 patients, and semaglutide had grown to around 3,900 per 100,000
Thats why the dosing schedule follows a slow, step-up approachstarting low and gradually increasing over several weeks
During the GHK-CU adjustment period, you might pause retinol entirely to reduce variables
But peptides alone arent a magic fix for hair loss
A data-based decision Commenting on Pittmans latest decision, Steve Benz, corporate vice president, general counsel at Novo Nordisk, said, We are pleased the court has rejected the compounders attempts to undermine FDAs data-based decision that the shortage of Wegovy and Ozempic is resolved. FDAs determination was based on a thorough review of Novo Nordisks stable and growing supply of these important FDA-approved medicines
Small portions, protein first, plenty of water